Making A.I.’s vile claims and made-up facts even worse is the fact that these chatbots are designed to be liked. They flatter ...

Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

Investing.com -- Sanofi (NASDAQ: SNY) has started shipping its flu vaccine portfolio for the 2025-2026 season to health facilities across the United States, the company announced today. The vaccine ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...

Zipline drones help to deliver blood supplies to hospitals across rural western Rwanda, helping to cut waiting times from ...

The number of measles cases in the U.S. has reached a 33-year record high, years after it was officially eliminated in the ...

Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated coverage of Novavax Inc.

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and ...

Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...